Article
Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Jan 2013
Benedetti Francesco, Bollettini Irene, Barberi Ignazio, Radaelli Daniele, Poletti Sara, Locatelli Clara, Pirovano Adele, Lorenzi Cristina, Falini Andrea, Colombo Cristina, Smeraldi Enrico
Abstract excerpt
Lithium is the mainstay for the treatment of bipolar disorder (BD) and inhibits glycogen synthase kinase 3-β (GSK3-β). The less active GSK3-β promoter gene variants have been associated with less detrimental clinical features of BD. GSK3-β gene variants and lithium can influence brain gray matter structure in psychiatric conditions. Diffusion tensor imaging (DTI) measures of white matter (WM) integrity showed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
